Rheumatoid Arthritis Database

The objective of the database is to include all information on biologic DMARDs as well as synthetic DMARDs currently approved or in development. The indications are rheumatoid arthritis (RA), psoriatic arthritis (PsA), or psoriasis (PSO).

A total of 129 references were selected for inclusion in the database, representing clinical outcomes from 94 unique trials, 301 unique treatment arms and about 38,460 patients. Download an information sheet for the RA database.